2 minute read

PULMONARY VASCULAR Disease

Our Comprehensive Pulmonary Vascular Disease Program offers coordinated, multidisciplinary expertise by a team of specialists in cardiology, pulmonary hypertension, vascular medicine, anticoagulation management, hematology, emergency medicine, hospital medicine, interventional cardiology, interventional radiology, and cardiothoracic surgery.

Patients have access to high-quality, progressive care across the entire spectrum of disease, including acute and chronic pulmonary embolism (PE), pulmonary hypertension, specifically chronic thromboembolic pulmonary hypertension (CTEPH), and pulmonary veno-occlusive disease.

PULMONARY ARTERIAL HYPERTENSION (PAH) AND MEDICALLY TREATED PULMONARY HYPERTENSION

• Our Pulmonary Hypertension Program is the largest and most experienced program in the state, and one of the largest in the country.

• U-M Health was pivotal in the clinical trials for PAH that led to the first drug in a decade approved for use in the spring of 2024. We also offer multiple Phase 2 and Phase 3 clinical trials of novel therapies for PAH and pulmonary hypertension associated with interstitial lung disease.

• We are a comprehensive, single resource for the care and treatment of patients who live with PAH.

First in Michigan to be accredited as a CENTER OF COMPREHENSIVE CARE by the Pulmonary Hypertension Association

PULMONARY EMBOLISM (PE) AND CTEPH

• The Frankel CVC is a center of excellence with specific expertise in pulmonary endarterectomy and balloon pulmonary angioplasty (BPA). As the only center in Michigan to offer these procedures, we are a regional referral center for CTEPH.

• To deliver optimally integrated care across health systems, we host monthly virtual care coordination conferences with our statewide referring physician community. Patients who are not eligible for the complex, open-heart endarterectomy procedure are treated with minimally invasive BPA. Our highly trained specialists routinely perform pulmonary angiogram and BPA.

• We staff a dedicated, multidisciplinary, 24-hour oncall pulmonary vascular disease service available to referring physicians. This service is a gateway to our pulmonary embolism response team (PERT) as well as our inpatient and outpatient specialized care teams, providing seamless coordination of medical, interventional, and open surgical management.

This article is from: